Quanterix Corporation Common Stock QTRX

$2.86 -5.30% at last close
Market Cap$135.79 million
P/E Ratio—
Div Yield—
Volume622.0K
52-Week Range $2.15$8.77

Analyst Ratings

Consensus
Hold — 0 Buy · 2 Hold · 0 Sell (2 analysts)
Avg. Price Target
$3.50 (+22.4% upside)

Full QTRX forecast & analyst actions →

Key Stats

Today's Range
$2.85 – $3.10
50-Day Range
$2.37 – $3.98
52-Week Range
$2.15 – $8.77
Volume
622K shs
Average Volume
512K shs
Market Cap
$135.79 million
P/E Ratio
—
Dividend Yield
—

Short Interest

Short Interest
0.04%
Days to Cover
1.00

About Quanterix Corporation Common Stock

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Sector
LABORATORY ANALYTICAL INSTRUMENTS
Employees
450
Exchange
XNAS
Listed
2017-12-07

Related Stocks

Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.